Executive

BARD1 has an experienced board and management team with a track record in healthcare leadership, diagnostics development and commercialisation.

Dr Leearne Hinch | Chief Executive Officer

Dr Leearne Hinch BSc, BVMS, MBA is an experienced biotechnology executive and life sciences commercialisation consultant. Leearne has a strong track record in company leadership, business strategy, fundraising, sales, business development and technology commercialisation. She has held senior executive, management and consulting positions in ASX-listed biotechnology, multinational and private companies where she led the development and commercialisation of multiple diagnostic, device, therapeutic and animal health products. Leearne holds Bachelor of Science, Bachelor of Veterinary Medicine and Surgery, and a Master of Business Administration.

Tony Di Pietro | Chief Financial Officer & Company Secretary

Tony Di Pietro B. Comm, CA, AGIA, MAICD is a Chartered Accountant with significant corporate accounting experience, gained both in Australia and the UK. He holds a Graduate Diploma of Applied Corporate Governance from the Governance Institute of Australia and is a member of the Australian Institute of Company Directors. Tony has held senior roles in the Biotechnology/ MedTech industry for the past 15 years including Sienna Cancer Diagnostics Ltd and gained valuable experience in other industry sectors at BHP Ltd, ExxonMobil Ltd, HSBC Ltd and Wilson Group.

Dr Peter French | Chief Scientific Officer

Dr Peter French BSc, MSc, PhD, MBA is a biotechnology executive and respected scientist. He has a successful track record in commercialising medical innovations with over 40 years’ scientific expertise in cell and molecular biology and over 40 peer reviewed publications across oncology, immunology, microbiology and neuroscience. His previous industry roles included providing strategic and scientific consulting services, executive director of AusDiagnostics Pty Ltd, Bioxyne Ltd and BCAL Diagnostics, Managing Director of Benitec Biopharma Ltd, and founder and non-executive director of Cryosite Ltd (ASX:CTE). Dr French also had a successful academic career as Principal Scientist at the Centre for Immunology, St Vincent’s Hospital and Post-Doctoral Research Scientist at the Children’s Medical Research Foundation. He was awarded the Faculty of Science Alumni Achievement Award for Innovation and Entrepreneurship in 2019 from the University of Sydney.